Associated Medical Conditions for Carcinoma

๐Ÿ“น Explaining this page and it's appropriate use.
The following is based on bacteria published studies. These are report on the averages of a group of patients; they do not apply to all patients and are not necessary predictive.

For some medical conditions there are hundreds of bacteria shifts reported, for others only a few. The Percentage is based on the least number. If there are matches 8 matches for a condition that has 10 known bacteria shifts, against a condition that has 50 bacteria shifts. It will be 8/10 or 80% and not 8/50= 16%. The count of possible bacteria is shown for reference.

Associations

Limited to conditions with 5 or more bacteria

Name Overlap Percent Prevalance in Population Matches Bacteria in From Bacteria in To
Alzheimer's disease 22 % 10% 11 50 51
Autism 35.3 % 2% 18 110 51
Ulcerative colitis 43.1 % 0.1% 22 108 51
Schizophrenia 29.4 % 0.75% 15 93 51
Ankylosing spondylitis 43.1 % 7% 22 520 51
Mood Disorders 33.3 % 29.7% 2 6 51
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 45.1 % 0.86% 23 134 51
Psoriasis 21.7 % 3% 10 46 51
Obesity 15.7 % 42.4% 8 104 51
Multiple Sclerosis 31.4 % 0.5% 16 100 51
Osteoporosis 22.7 % 9.4% 5 22 51
Obesity 54.9 % 42.4% 28 55 51
ME/CFS without IBS 23.1 % 0.4% 6 26 51
Multiple system atrophy (MSA) 14.3 % 0.005% 3 21 51
Metabolic Syndrome 14.3 % 21% 1 7 51
Amyotrophic lateral sclerosis (ALS) Motor Neuron 16.3 % 0.005% 7 43 51
ME/CFS with IBS 21.1 % 2.8% 4 19 51
Liver Cirrhosis 84.3 % 0.27% 43 678 51
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 29.4 % 25% 15 76 51
Parkinson's Disease 27.5 % 1% 14 90 51
Chronic Kidney Disease 20 % 15% 7 35 51
Systemic Lupus Erythematosus 25.5 % 0.15% 13 66 51
Depression 27.5 % 8% 14 81 51
Irritable Bowel Syndrome 15.7 % 15% 8 62 51
IgA nephropathy (IgAN) 10.3 % 0.001% 3 29 51
Insomnia 20 % 30% 2 10 51
Hyperlipidemia (High Blood Fats) 20 % 33% 5 25 51
hypertension (High Blood Pressure 33.3 % 47% 2 6 51
hypercholesterolemia (High Cholesterol) 22.2 % 12% 2 9 51
Allergic Rhinitis (Hay Fever) 13.9 % 7.8% 5 36 51
gallstone disease (gsd) 46.7 % 5% 7 15 51
Graves' disease 25 % 0.5% 2 8 51
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 16.7 % 27.8% 4 24 51
Functional constipation / chronic idiopathic constipation 19.5 % 14% 8 41 51
Epilepsy 20 % 0.84% 5 25 51
Fibromyalgia 18.9 % 1.12% 7 37 51
Inflammatory Bowel Disease 23.5 % 1.3% 12 66 51
Type 1 Diabetes 13.7 % 0.19% 7 52 51
COVID-19 13.9 % 50% 5 36 51
Cerebral Palsy 47.1 % 0.2% 8 17 51
Colorectal Cancer 45.1 % 4.3% 23 296 51
Celiac Disease 31.4 % 1.4% 16 67 51
Chronic Fatigue Syndrome 17.6 % 3% 9 55 51
Coronary artery disease 18.8 % 6.7% 3 16 51
Bipolar Disorder 24.2 % 3% 8 33 51
Atherosclerosis 45.1 % 50% 23 524 51
Crohn's Disease 80.4 % 0.3% 41 141 51
Small Intestinal Bacterial Overgrowth (SIBO) 18.8 % 52% 3 16 51
Brain Trauma 18.2 % 0.367% 4 22 51
Sjögren syndrome 36.6 % 1.2% 15 41 51
Stress / posttraumatic stress disorder 23.5 % 5.2% 12 56 51
Type 2 Diabetes 72.5 % 10.8% 37 267 51
ADHD 17 % 9.4% 8 47 51
Hashimoto's thyroiditis 28.6 % 0.35% 4 14 51

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 ยงโ€ฏ1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.